US 8119809
AMPK-activating heterocycloalkyloxy(hetero)aryl carboxamide, sulfonamide and amine compounds and methods for using the same
granted A61PA61P3/00A61P3/06
Quick answer
US patent 8119809 (AMPK-activating heterocycloalkyloxy(hetero)aryl carboxamide, sulfonamide and amine compounds and methods for using the same) held by Rigel Pharmaceuticals, Inc. expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61P, A61P3/00, A61P3/06, A61P3/08, A61P3/10